The Bipartisan Heroin Task Force, led by Representatives Annie Kuster (D-NH), Tom MacArthur (R-NJ), Brian Fitzpatrick (R-PA), and Donald Norcross (D-NJ), is urging Congress to protect the Office of National Drug Control Policy (ONDCP)’s budget and keep its funding to at least current levels.  Additionally, the Task Force asked Congress to reject any further cuts to ONDCP’s funding, prevent reductions to its staff, and keep the High Intensity Drug Trafficking Areas (HIDTA) and Drug-Free Communities (DFC) programs within ONDCP’s jurisdiction. 45 additional members joined the co-chairs and vice-chairs in this request.

Recently, the Bipartisan Heroin Task Force urged OMB Director Mick Mulvaney to adequately fund the ONDCP. Last year, the group successfully advocated against any cuts to ONDCP.

“We are losing over 170 Americans every day to the opioid crisis,” wrote the Bipartisan Heroin Task Force. “Both the Administration and Members of Congress from both parties have indicated that addressing this epidemic is a matter of highest priority.  We believe that a strong ONDCP is a critical component of an effective and aggressive response to the devastation that heroin, opioids, and other drugs are causing in our communities.  Reducing its budget, staff, and role will only harm ONCDP’s ability to fulfill this unique and already difficult mission.”

Full Text of Letter:

Dear Chairman Frelinghuysen and Ranking Member Lowey:

As members of the Bipartisan Heroin Task Force, we urge you to protect the Office of National Drug Control Policy (ONDCP)’s budget and keep its funding to at least current levels.  We ask you to reject any further cuts to ONDCP’s funding, prevent reductions to its staff, and keep the High Intensity Drug Trafficking Areas (HIDTA) and Drug-Free Communities (DFC) programs within ONDCP’s jurisdiction.

As you know, the Centers for Disease Control and Prevention (CDC) has reported that there were more than 63,600 drug overdose deaths in the United States in 2016.   The majority of those involved prescription opioids, heroin, or synthetic opioids like fentanyl.  We are losing over 170 Americans every day to this crisis.

Both the Administration and Members of Congress from both parties have indicated that addressing this epidemic is a matter of highest priority.  We believe that a strong ONDCP is a critical component of an effective and aggressive response to the devastation that heroin, opioids, and other drugs are causing in our communities. 

ONDCP not only provides indispensable expertise and analysis, it helps develop and coordinate drug policy across the many departments and agencies of the Federal government, including the Department of Justice (DOJ) and Drug Enforcement Administration (DEA), as well as the Substance Abuse and Mental Health Services Administration (SAMHSA), the CDC and other efforts within the Department of Health and Human Services (HHS). This is a challenging task under any circumstances.  Reducing its budget, staff, and role will only harm ONDCP’s ability to fulfill this unique and already difficult mission.

In addition, there are HIDTA-designated counties in 49 states, as well as Puerto Rico, the U.S. Virgin Islands, and the District of Columbia. Likewise, the Drug-Free Communities Support program is an important grant program that aims to strengthen collaboration among communities, public agencies, and private non-profit agencies to reduce substance abuse among youth.  These programs do an enormous amount of good and we express our strong support for them. We also note that actively managing these programs keeps ONDCP directly engaged with those on the front lines of this fight in a way that might not otherwise be, which greatly enhances the quality of its policy and coordination work. We suggest that report language describing how ONDCP oversight of these programs strengthens the office’s mission may be helpful in addressing this question in the future.

We respectfully request that you support the important work being conducted by the ONDCP. Thank you for your consideration.

Sincerely,

Representatives Mark DeSaulnier (D-CA), Debbie Dingell (D-MI), Glenn Thompson (R-PA), Tom O'Halleran (D-AZ), Elizabeth Esty (D-CT), Barbara Comstock (R-VA), Elise Stefanik (R-NY), Ryan Costello (R-PA), James McGovern (D-MA), Claudia Tenney (R-NY), Brian Fitzpatrick (R-PA), Cheri Bustos (D-IL), Steve Knight (R-CA), Sean Patrick Maloney (D-NY), Lois Frankel (D-FL), Scott Peters (D-CA),  Lisa Blunt Rochester (D-DE), Keith Rothfus (R-PA), Bill Foster (D-IL), Luke Messer (R-IN), Alex Mooney (R-WV), Seth Moulton (D-MA), Andy Barr (R-KY), Bradley Schneider (D-IL), John Larson (D-CT), Mark Takano (D-CA), Kathleen Rice (D-NY),  Carol Shea-Porter (D-NH), Donald Norcorss (D-NJ), Hakeem Jeffries (D-NY), Kyrsten Sinema (D-AZ), Chellie Pingree (D-ME), Stephen Lynch (D-MA), Peter Welch (D-VT), Patrick Meehan (R-PA), Joe Courtney (D-CT), William Keating (D-MA), Michael Turner (R-OH), Bob Gibbs (R-OH), Ted Deutch (D-FL), Brian Higgins (D-NY), and Julia Brownley (D-CA) joined the co-chairs on this request.

###